Rem3dy's £1.4m round signals cross‑border faith in Midlands startups
This article covers Rem3dy Health, a Midlands‑founded health‑tech startup, which has raised £1.4m from Amsterdam‑based Borski Fund and Future Planet Capital Regional to accelerate global expansion and R&D for its personalised nutrition brand, Nourished. The funding is intended to support international sales and further development of its 3D‑printed personalised supplements and highlights growing cross‑border investor interest in the West Midlands.
Rem3dy Health, a Midlands-founded health‑tech scale‑up, has raised £1.4 million from Amsterdam-based Borski Fund and Future Planet Capital Regional to accelerate global expansion and R&D for its personalised nutrition brand, Nourished. The deal, announced at Birmingham Tech Week’s Scale‑Up Summit, underlines increasing cross‑border investor interest in the West Midlands innovation scene.
Why it matters
The funding shows investors outside London are willing to write meaningful cheques for regionally based founders. That matters at a time when the West Midlands is trying to close a persistent funding gap and build local pathways from prototype to scale.
Rem3dy’s round was announced during a panel run by The Lifted Project, a Rose Review and Treasury‑aligned initiative designed to improve access to capital for high‑growth, women‑led businesses. The deal also ties into broader regional activity, including the recent £30 million Inclusive Innovation Catalyst venture studio and the West Midlands Co‑Investment Fund.
Inside the product
Rem3dy Health makes Nourished, a personalised nutrition product that uses proprietary 3D printing technology to create on‑demand, preventative health supplements tailored to individual needs. The new capital will be used to expand international sales and to continue R&D on the 3D printing platform and personalised formulations.
### Who's backing the round
Who’s backing the round
The round totals £1.4 million, split between Borski Fund and Future Planet Capital Regional. Borski, which is Amsterdam based and focuses on backing high‑growth, women‑led ventures, committed £900,000. Future Planet Capital Regional invested £500,000 and manages the West Midlands Co‑Investment Fund, a vehicle aimed at attracting external capital into the region.
In the announcement, Jen Roberts‑Woods, Investment Associate at Borski Fund, said:
The Borski Fund is proud to back Rem3dy Health, an innovative UK company with worldwide ambitions. Our collaboration with Future Planet Capital highlights the power of international investor partnerships to drive innovation and support exceptional founders. From our first meeting, Melissa’s vision and drive towards realising Rem3dy Health’s global potential was unmissable. The Borski Fund looks forward to working closely with Rem3dy Health as it continues to scale and shape the future of personalised health innovations
In the announcement, Rupert Lyle at Future Planet Capital Regional, said:
Through the West Midlands Co‑Investment Fund, we’re proving that the region can be a launchpad for world‑class innovation. Rem3dy Health’s growth story is an outstanding example of what happens when regional founders are backed by both local and global capital: the outcomes are both commercially and socially transformative
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
Founder perspective
Melissa Snover, founder and CEO of Rem3dy Health, framed the round as both a company milestone and a signal for the wider Midlands ecosystem. Snover has previously raised more than £20 million across her ventures and is positioning Rem3dy to compete internationally from Birmingham.
In the announcement, Melissa Snover, Founder and CEO at Rem3dy Health, said:
This latest round marks a huge milestone not just for Rem3dy Health, but for the Midlands innovation scene. Both Borski and Future Planet Capital share our belief that world‑class innovation doesn’t have to start – or stay – in London. This investment proves that regional founders can raise global capital and scale globally from right here in Birmingham.
The bigger picture
Rem3dy’s funding sits at the intersection of two trends: increasing cross‑border investment into UK regional startups and growing attention to health‑tech and personalised healthcare. While headline investments and new programmes such as the Inclusive Innovation Catalyst signal progress, the West Midlands still faces a long tail of undercapitalised founders. Initiatives like The Lifted Project and the West Midlands Co‑Investment Fund aim to address that imbalance by combining local support with international capital.
For the UK and wider Europe, the deal is a reminder that capital and innovation are spreading beyond capital cities. How effectively regional ecosystems convert early signal investments into sustained scale‑ups will be a key watchpoint for policymakers and VCs in the coming years.
They've invested in Rem3dy Health
Get to know these healthtech investors
Click here for a full list of 7,233+ startup investors in the UK